🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesNNT for MACE prevention — what worked for you? Page 2

NNT for MACE prevention — what worked for you?

Dr.LipidDallas Wed, Jan 24, 2024 at 1:42 AM 16 replies 2,206 viewsPage 2 of 4
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Jan 24, 2024 at 3:41 AM#6
Dr.KarenChen said:
I want to bring up the cardiovascular angle on cardiovascular risk.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The "earlier than weight loss explains" argument is weaker than this thread makes it sound. Blood pressure and inflammatory markers move fast and are downstream of early weight loss, so the mechanism is not as cleanly separable as the summaries imply.

That is the short version; the long version is somebody else's post.

8 3josh_phd_bmore, roxy_nash, tony_orlando and 5 others
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Jan 24, 2024 at 4:27 AM#7
Dr.LipidDallas said:
Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.
Dr.LipidDallas said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

7 2Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 4 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Jan 24, 2024 at 5:13 AM#8
sarah.morrison said:
The "earlier than weight loss explains" argument is weaker than this thread makes it sound.

I'm 55 years old and want to share my perspective on cardiovascular risk as an older member of this community.

My doctor was initially hesitant because of my age, but the SELECT trial included patients up to 72 and showed consistent benefit across age groups. We started at the lowest dose with closer monitoring.

8 months later: down 55 lbs, off atorvastatin, A1C from 7.0% to 5.4%. My cardiologist is thrilled. cardiovascular risk is absolutely relevant for older adults — don't let anyone tell you otherwise.

6 1BrianDallas92, labquiet_amy, emily_PDX and 3 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Jan 24, 2024 at 5:59 AM#9

One thing that is still open after MikeKY_noInsulin’s answer:

How would you tell the difference between that and the alternative explanation?

5 0NicoleRaleigh, james_edin, FranDenver and 2 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Jan 24, 2024 at 9:37 AM#10
CarlaRPh_TPA said:
I'm 55 years old and want to share my perspective on cardiovascular risk as an older member of this community.

6 month update on cardiovascular risk: down 51 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

Last edited: Jan 24, 2024 at 11:37 AM
23 21Dr.PulmRoch, maya_sedona, stefan_berlin and 20 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register